586 related articles for article (PubMed ID: 19371189)
1. Drug-eluting stents: a comprehensive appraisal.
Butt M; Connolly D; Lip GY
Future Cardiol; 2009 Mar; 5(2):141-57. PubMed ID: 19371189
[TBL] [Abstract][Full Text] [Related]
2. Drug eluting stents: developments and current status.
Khan W; Farah S; Domb AJ
J Control Release; 2012 Jul; 161(2):703-12. PubMed ID: 22366546
[TBL] [Abstract][Full Text] [Related]
3. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
4. Coronary artery stents: Part I. Evolution of percutaneous coronary intervention.
Newsome LT; Kutcher MA; Royster RL
Anesth Analg; 2008 Aug; 107(2):552-69. PubMed ID: 18633035
[TBL] [Abstract][Full Text] [Related]
5. Understanding the drug-eluting stent trials.
Coolong A; Kuntz RE
Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
[TBL] [Abstract][Full Text] [Related]
6. Is there a preferable DES in diabetic patients? A critical appraisal of the evidence.
Byrne RA; Kastrati A
Catheter Cardiovasc Interv; 2008 Dec; 72(7):944-9. PubMed ID: 19021280
[TBL] [Abstract][Full Text] [Related]
7. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
[TBL] [Abstract][Full Text] [Related]
8. XIENCE V everolimus-eluting coronary stent system: a novel second generation drug-eluting stent.
Beijk MA; Piek JJ
Expert Rev Med Devices; 2007 Jan; 4(1):11-21. PubMed ID: 17187467
[TBL] [Abstract][Full Text] [Related]
9. Current drug-eluting stents in complex patients and lesions.
Elezi S; Dibra A; Schömig A; Kastrati A
Minerva Cardioangiol; 2006 Feb; 54(1):5-22. PubMed ID: 16467738
[TBL] [Abstract][Full Text] [Related]
10. Current status of the Xience V® everolimus-eluting coronary stent system.
Claessen BE; Caixeta A; Henriques JP; Piek JJ
Expert Rev Cardiovasc Ther; 2010 Oct; 8(10):1363-74. PubMed ID: 20936921
[TBL] [Abstract][Full Text] [Related]
11. The short-term effect on restenosis and thrombosis of a cobalt-chromium stent eluting two drugs in a porcine coronary artery model.
Huang Y; Venkatraman SS; Boey FY; Umashankar PR; Mohanty M; Arumugam S
J Interv Cardiol; 2009 Oct; 22(5):466-78. PubMed ID: 19627432
[TBL] [Abstract][Full Text] [Related]
12. [State of treatment of coronary artery disease by drug releasing stents].
Müller R; Büllesfeld L; Gerckens U; Grube E
Herz; 2002 Sep; 27(6):508-13. PubMed ID: 12378395
[TBL] [Abstract][Full Text] [Related]
13. A stent is not just a stent: Stent construction and design do matter in its clinical performance.
Lau KW; Johan A; Sigwart U; Hung JS
Singapore Med J; 2004 Jul; 45(7):305-11; quiz 312. PubMed ID: 15221045
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel-eluting balloon: from bench to bed.
De Labriolle A; Pakala R; Bonello L; Lemesle G; Scheinowitz M; Waksman R
Catheter Cardiovasc Interv; 2009 Apr; 73(5):643-52. PubMed ID: 19309715
[TBL] [Abstract][Full Text] [Related]
15. Drug-eluting stent thrombosis.
Stähli BE; Camici GG; Tanner FC
Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):45-52. PubMed ID: 19124388
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive balloon postdilatation after stent deployment: is it still necessary with drug-eluting stents?
Brodie BR
J Interv Cardiol; 2006 Feb; 19(1):43-50. PubMed ID: 16483339
[TBL] [Abstract][Full Text] [Related]
17. Therapy insight: diabetes and drug-eluting stents.
Legrand V
Nat Clin Pract Cardiovasc Med; 2007 Mar; 4(3):143-50. PubMed ID: 17330126
[TBL] [Abstract][Full Text] [Related]
18. Clinical evidence on polymer-based sirolimus and paclitaxel eluting stents.
Iijima R; Mehilli J; Schömig A; Kastrati A
Minerva Cardioangiol; 2006 Oct; 54(5):539-55. PubMed ID: 17019392
[TBL] [Abstract][Full Text] [Related]
19. Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.
Waksman R; Pakala R
EuroIntervention; 2009 Dec; 5 Suppl F():F36-42. PubMed ID: 22100674
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.
Ducrocq G; Serebruany V; Tanguay JF
Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):939-53. PubMed ID: 17867923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
